Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 21;12(2):111.
doi: 10.3390/children12020111.

Comment on Lombardo et al. The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes. Children 2022, 9, 1087

Timothy P Foster  1 , Desmond Schatz  1
Affiliations

Comment on Lombardo et al. The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes. Children 2022, 9, 1087

Timothy P Foster et al. Children (Basel). .

Abstract

As Type 1 diabetes pediatric physician-scientists, we read the publication "The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes" by Lombardo et al [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment on

  • Children (Basel). 9:1087.

References

    1. Lombardo F., Bombaci B., Alibrandi A., Visalli G., Salzano G., Passanisi S. The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes. Children. 2022;9:1087. doi: 10.3390/children9071087. - DOI - PMC - PubMed
    1. Omar M.A., El-Kafoury A.A., El-Araby R.I. Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors. BMC Res. Notes. 2011;4:290. doi: 10.1186/1756-0500-4-290. - DOI - PMC - PubMed
    1. Barlas T., Yalcin M.M., Coskun M., Demirel D., Altinova A.E., Toruner F.B., Karakoc M.A., Yetkin I., Akturk M. Evaluation of Lipohypertrophy in Patients with Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion. Endocr. Pract. 2023;29:119–126. doi: 10.1016/j.eprac.2022.11.008. - DOI - PubMed
    1. Kalus A., Shinohara M.M., Wang R., Baran J.D., Dong X., Khakpour D., Lu J., Hirsch I.B. Evaluation of Insulin Pump Infusion Sites in Type 1 Diabetes: The DERMIS Study. Diabetes Care. 2023;46:1626–1632. doi: 10.2337/dc23-0426. - DOI - PubMed
    1. Frid Anders H., Gillian K., Giorgio G., Serge H., Debbie H., Hirsch Laurence J., Smith Mike J., Regine W., Bode Bruce W., Hirsch Irl B., et al. New Insulin Delivery Recommendations. Mayo Clin. Proc. 2016;91:1231–1255. doi: 10.1016/j.mayocp.2016.06.010. - DOI - PubMed

LinkOut - more resources